The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
S Choudhary, K Sharma, O Silakari - Microbial pathogenesis, 2021 - Elsevier
Abstract COVID-19, caused by SARS-CoV-2, emerged as the deadliest outbreak that has
now become a serious health issue to mankind. Activation of inflammatory signaling …
now become a serious health issue to mankind. Activation of inflammatory signaling …
[HTML][HTML] Remdesivir and its antiviral activity against COVID-19: A systematic review
Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the
causative agent of COVID-19. Methods Available publications were systematically explored …
causative agent of COVID-19. Methods Available publications were systematically explored …
[HTML][HTML] Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future …
Abstract Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …
etiology of 'Corona Virus Disease-2019'(COVID-19); formerly referred as 'novel-Coronavirus …
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
S Noreen, I Maqbool, A Madni - European journal of pharmacology, 2021 - Elsevier
The current outbreak of novel COVID-19 challenges the development of an efficient
treatment plan as soon as possible. Several promising treatment options stand out as …
treatment plan as soon as possible. Several promising treatment options stand out as …
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality
Y Que, C Hu, K Wan, P Hu, R Wang, J Luo… - International reviews …, 2022 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) erupted in Hubei Province of China in December …
syndrome coronavirus 2 (SARS-CoV-2) erupted in Hubei Province of China in December …
[HTML][HTML] Flavonoids against the SARS-CoV-2 induced inflammatory storm
The disease severity of COVID-19, especially in the elderly and patients with co-morbidities,
is characterized by hypercytokinemia, an exaggerated immune response associated with an …
is characterized by hypercytokinemia, an exaggerated immune response associated with an …
[HTML][HTML] COVID-19 and the clinical course of rheumatic manifestations
The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
SARS-CoV-2 is a novel coronavirus that severely affects the respiratory system, is the cause
of the COVID-19 pandemic, and is projected to result in the deaths of 2 million people …
of the COVID-19 pandemic, and is projected to result in the deaths of 2 million people …
[HTML][HTML] Disharmonic inflammatory signatures in COVID-19: augmented neutrophils' but impaired monocytes' and dendritic cells' responsiveness
Z Parackova, I Zentsova, M Bloomfield, P Vrabcova… - Cells, 2020 - mdpi.com
COVID-19, caused by SARS-CoV-2 virus, emerged as a pandemic disease posing a severe
threat to global health. To date, sporadic studies have demonstrated that innate immune …
threat to global health. To date, sporadic studies have demonstrated that innate immune …
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
TI Hariyanto, A Kurniawan - … & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aims The number of positive and death cases from coronavirus disease
2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is …
2019 (COVID-19) is still increasing. The identification of risk factors for severe outcomes is …